Becton Dickinson
Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BDX
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional.
BDX Key Statistics
Stock Snapshot
Becton Dickinson(BDX) stock is priced at $182.27, giving the company a market capitalization of 49.65B. It carries a P/E multiple of 54.34 and pays a dividend yield of 2.33%.
During the trading session on 2026-10-08, Becton Dickinson(BDX) shares reached a daily high of $182.29 and a low of $178.90. At a current price of $182.27, the stock is +1.9% higher than the low and still -0.0% under the high.
Trading activity shows a volume of 572.44K, compared to an average daily volume of 1.69M.
Over the past 52 weeks, Becton Dickinson(BDX) stock has traded between a high of $193.07 and a low of $129.03.
Over the past 52 weeks, Becton Dickinson(BDX) stock has traded between a high of $193.07 and a low of $129.03.
BDX News
Becton Dickinson reported positive nine month data from the AGILITY trial for its Revello Vascular Covered Stent and agreed a long term U.S. government partners...
Barclays analyst Christopher Pasquale last night initiated coverage of Becton Dickinson (BDX) with an Underweight rating and $165 price target The firm rolled o...
BD announced positive nine-month results from the iliac cohort of the AGILITY Investigational Device Exemption trial evaluating the Revello Vascular Covered Ste...
Analyst ratings
50%
of 18 ratingsMore BDX News
Travis Steed, an analyst from Bank of America Securities, maintained the Hold rating on Becton Dickinson. The associated price target remains the same with $200...
Becton Dickinson (BDX) just put two big operational pieces on the table, naming Ferass Abuzaina as worldwide president of its Surgery unit and outlining a multi...
U.S. medical device company Becton Dickinson (BDX) has agreed to invest $19 billion in the U.S. over several years, the company announced in a statement on Tues...
Becton Dickinson entered an agreement with the Trump administration to expand domestic manufacturing. Patrick T. Fallon / Bloomberg News Becton Dickinson BDX 2...
Becton Dickinson (BDX) announced a partnership with the U.S. Government to expand domestic manufacturing and strengthen the resilience of supply chains for esse...
Becton Dickinson and Co. (NYSE:BDX) plans to invest $3 billion in U.S. medical-product manufacturing, President Donald Trump said. In a Truth Social post late...
Becton, Dickinson and Co (BDX) announced an update on their ongoing clinical study. Becton, Dickinson and Co. (BDX) and C. R. Bard are running a pilot study ca...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.